Outcomes in Systemic Sclerosis-Associated Interstitial Lung Disease Based on Serological Profiles: Focus on Anti-Centromere and Anti-RNA Polymerase III Antibodies

By sjmartinez • April 16, 2025

Volkmann ER, Assassi S, Denton CP, Simonovska R, Sambevski S, Alves M, Bernstein EJ. Outcomes in Systemic Sclerosis-Associated Interstitial Lung Disease Based on Serological Profiles: Focus on Anti-Centromere and Anti-RNA Polymerase III Antibodies. J Rheumatol. 2025 Apr 15:jrheum.2024-1063. doi: 10.3899/jrheum.2024-1063. Epub ahead of print. PMID: 40233987.

Tags: Publications, Rheumatology

Five-Year Follow-Up Analysis of ZUMA-5: Axicabtagene Ciloleucel in Relapsed/Refractory Indolent Non-Hodgkin Lymphoma

Neelapu SS, Chavez JC, Sehgal AR, Epperla N, Ulrickson ML, Bachy E, Munshi PN, Casulo C, Maloney DG, de Vos S, Reshef R, Leslie LA,[...]

Artificial intelligence and computer-aided diagnosis in diagnostic decisions: 5 questions for medical informatics and human-computer interface research

Brunyé TT, Mitroff SR, Elmore JG. Artificial intelligence and computer-aided diagnosis in diagnostic decisions: 5 questions for medical informatics and human-computer interface research. J Am[...]

FAP Expression in Renal Tumors Assessed by [68Ga]Ga-FAPI-46 PET Imaging and FAP Immunohistochemistry: A Case Series of Six Patients from the Prospective Exploratory Trial NCT04147494

Holzgreve A, Unterrainer LM, Flores K, Lam EC, Mona CE, Czernin J, Shuch BM, Sisk AE Jr, Calais J. FAP Expression in Renal Tumors Assessed[...]